TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AAPG

Ascentage Pharma Group International

Healthcare · Biotechnology

14.90$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Ascentage Pharma Group International (AAPG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 558 million CNY. Tick rows to compare them in a chart.

All figures in millions of CNY.

Tick rows to compare them in a chart (up to 4)

Income Statement AAPG
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
7.7 6.3 6.8 15 12 28 210 222 981 558
0.3 – – 2.1 2.0 3.3 22 31 29 132
7.4 6.3 6.8 12 10 25 188 191 952 427
103 119 250 464 565 766 743 707 947 1,083
18 13 89 99 63 144 171 181 187 600
122 137 333 595 674 958 1,038 1,064 1,321 1,606
-115 -131 -345 -583 -664 -870 -850 -873 -370 -1,179
3.3 58 37 4.3 6.3 17 53 96 64 53
-108 -120 -360 -1,482 -675 -832 -887 -933 -395 -1,202
– -1.6 -1.6 -1.6 2.2 -50 -4.2 -7.2 10 6.8
-108 -119 -345 -1,481 -678 -782 -883 -926 -405 -1,209
-116 -50 -326 -1,474 -652 -798 -787 -744 -238 -1,095

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?